Clinical trials in Logrono – page 2

Innovative studies focusing on non-muscle invasive bladder cancer treatment, comparing electric current-administered mitomycin C with standard immunotherapy. Research includes evaluation of novel biomarkers for tumor detection.

• Bladder Cancer Therapy
• Biomarker Detection

Advanced therapeutic approaches combining traditional and innovative treatment methods.

Clinical research examining treatment outcomes for severe acute alcoholic hepatitis, investigating the effectiveness of combination therapy using methylprednisolone and N-acetylcysteine.

• Liver Disease Management
• Combination Therapy Assessment

Focus on improving survival rates in severe cases.

Comprehensive studies on bacterial infections, including Pseudomonas aeruginosa bacteremia and Enterobacteriales infections. Evaluation of optimal antibiotic treatment durations and alternative therapeutic approaches.

• Antimicrobial Therapy
• Treatment Duration Optimization
• Bacterial Resistance

Advancing antimicrobial stewardship through evidence-based research.

Breakthrough studies in multiple sclerosis treatment, comparing the efficacy of remibrutinib versus teriflunomide in managing relapsing forms of the disease.

• MS Treatment Innovation
• Relapse Prevention

Focused on improving quality of life for MS patients.

Investigation of treatment strategies for acute myocardial infarction, evaluating evolocumab's effectiveness in reducing cardiovascular events and hospitalizations.

• Heart Attack Management
• Preventive Cardiology

Emphasis on real-world clinical outcomes.